CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Methyl aminolevulinate (MAL) PDTdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00673933
NCT00673933Phase 2Completed
CompareCT.gov

A Blinded, Randomized, Intra-individual, Vehicle-controlled and Multi-centre Study of Photodynamic Therapy With MAL Cream in Patients With Skin Type V or VI With Acne Vulgaris

Photocure·interventional·Posted May 7, 2008·Updated Jul 12, 2013

In Brief

A Phase 2 clinical trial evaluating Methyl aminolevulinate (MAL) PDT for Acne Vulgaris. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 7, 2008
Enrollment StartMay 1, 2008
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 18.2 years ago

Interventions

Methyl aminolevulinate (MAL) PDTdrug

Cream application followed by illumination with red light